BRIEF published on 07/24/2025 at 14:16, 1 year 3 months ago FUTRUE GmbH Proposes Squeeze-Out for PharmaSGP Minority Shareholders Shareholders Compensation Squeeze-out PharmaSGP Futrue GmbH
PRESS RELEASE published on 07/24/2025 at 14:11, 1 year 3 months ago EQS-Adhoc: FUTRUE GmbH submits request to implement squeeze-out of minority shareholders of PharmaSGP Holding SE FUTRUE GmbH requests squeeze-out of minority shareholders by PharmaSGP Holding SE as it holds over 95% shares. Valuation ongoing for cash compensation determination Squeeze-out Minority Shareholders Cash Compensation PharmaSGP Holding SE Futrue GmbH
BRIEF published on 07/18/2025 at 12:02, 1 year 3 months ago PharmaSGP Holding SE Announces Delisting Offer by FUTRUE GmbH Shareholders Healthcare Products Delisting Offer PharmaSGP Futrue GmbH
PRESS RELEASE published on 07/18/2025 at 11:57, 1 year 3 months ago PharmaSGP Holding SE: Acceptance period for FUTRUE GmbH’s public delisting tender offer underway PharmaSGP Holding SE announces FUTRUE GmbH's public delisting tender offer acceptance period. Shareholders can tender shares for €28.00 cash consideration until August 11, 2025 Shareholders Tender Offer Delisting Cash Consideration PharmaSGP Holding SE
BRIEF published on 07/11/2025 at 08:06, 1 year 3 months ago PharmaSGP Holding SE Revises 2025 Revenue Forecast Adjusted EBITDA Revenue Adjustment PharmaSGP 2025 Forecast Geopolitical Uncertainty
PRESS RELEASE published on 07/11/2025 at 08:01, 1 year 3 months ago EQS-Adhoc: PharmaSGP Holding SE adjusts its revenues forecast for the full year 2025 PharmaSGP Holding SE adjusts full year 2025 revenue forecast due to current data evaluation. Adjusted forecast now €132.0-138.0 million. EBITDA expectation maintained EBITDA Revenue Forecast PharmaSGP Holding SE Adjusted Forecast 2025 Fiscal Year
BRIEF published on 06/26/2025 at 12:44, 1 year 4 months ago PharmaSGP Holding SE Holds Annual General Meeting 2025 Financial Results Dividend Policy Annual Meeting PharmaSGP 2025 Forecast
PRESS RELEASE published on 06/26/2025 at 12:39, 1 year 4 months ago PharmaSGP Holding SE holds 2025 Annual General Meeting PharmaSGP Holding SE reports on 2025 Annual General Meeting, with 91.12% share capital represented, €0.05 dividend per share approved, and confirmation of 2025 fiscal year forecast Annual General Meeting Dividend Forecast PharmaSGP Holding SE OTC Pharmaceuticals
BRIEF published on 06/18/2025 at 17:34, 1 year 4 months ago PharmaSGP SE to Redeem Shares Amid Upcoming Delisting Treasury Shares Delisting Squeeze-out Share Redemption PharmaSGP
PRESS RELEASE published on 06/18/2025 at 17:29, 1 year 4 months ago PharmaSGP SE plans to redeem own shares – conditions for squeeze-out under conversion law are met PharmaSGP SE plans to redeem treasury shares to optimize use of new authorization, leading to a squeeze-out possibility due to increased ownership percentage Share Buyback Treasury Shares Squeeze-out PharmaSGP Conversion Law
Published on 11/05/2026 at 13:29, 10 minutes ago Impauer Technologies Announces Official Release of PauerOne V2 Featuring Integrated PauerEarn Rewards Engine
Published on 11/05/2026 at 13:27, 12 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 11/05/2026 at 13:00, 39 minutes ago NOA Lithium Provides Update On 2026 Exploration Campaign
Published on 11/05/2026 at 13:00, 39 minutes ago Gold Terra Announces 6.61 g/t Gold over 7.35 Metres Including 31.6 g/t Gold over 1.1 Metres on the Campbell Shear Zone 103N Extension, Con Mine, Yellowknife, NWT
Published on 11/05/2026 at 13:00, 39 minutes ago Quebec Selects NiobiumX's Shipshaw Carbonatite as One of Five for Detailed Study; NiobiumX Announces Private Placement of Flow-Through Units
Published on 11/05/2026 at 13:15, 24 minutes ago Global Higher Education Forum Highlights Hong Kong’s Strategic Vision as International Talent Hub
Published on 11/05/2026 at 13:05, 33 minutes ago TR-1: Standard Form for Notification of Major Holdings
Published on 11/05/2026 at 13:05, 34 minutes ago Anaheim Bio Launches with €40 Million Series A Financing to Advance ANA-1 for Calcium Pyrophosphate Deposition Disease into the Clinic
Published on 11/05/2026 at 13:05, 34 minutes ago movement Acquires Technology and IP Assets of Swiss Digital Health Company dacadoo
Published on 11/05/2026 at 13:02, 36 minutes ago EQS-Adhoc: Borussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2026/2027 financial year
Published on 11/05/2026 at 10:16, 3 hours 23 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Published on 11/05/2026 at 07:00, 6 hours 39 minutes ago Eurazeo’s European asset management platform continues to gain momentum, driven by sustained international fundraising
Published on 11/05/2026 at 07:00, 6 hours 39 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Published on 11/04/2026 at 18:00, 19 hours 39 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
